Head-to-head · free

O'Reilly Automotive vs The Precision Peptide Company

ORLY vs PNGAF — return on capital, cash generation, margins and balance sheet side by side.

ORLY

0 / 0

measures where ORLY leads

PNGAF

0 / 0

measures where PNGAF leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureORLY · FY2025PNGAF
Revenue$17.8B—
Net income$2.5B—
Revenue growth (yearly, multi-year)54.9%—
Free cash flow$1.6B—
Free cash flow margin9.0%—
Net cash / (debt)——
ROIC38.0%—
Return on equity——
Gross margin51.6%—
Operating margin19.5%—
Net debt / EBITDA1.47x—

Figures are as reported by each company; latest fiscal year shown.

Where O'Reilly Automotive's cash went (FY2025)

Capital spending
$1.2B
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full ORLY profile →

Where The Precision Peptide Company's cash went

Not reported yet.

Full PNGAF profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons